The Europe Congestive Heart Failure (CHF) Treatment Devices Market would witness market growth of 5.2% CAGR during the forecast period (2022-2028).
CVDs are a set of illnesses characterized by structural or functional abnormalities in the heart and blood arteries that impact the heart's function. CVDs are one of the leading causes of death worldwide. Favorable reimbursement systems, like the Medicare system in the United States, are a major driver of this vertical's growth. Medical device businesses are now offering new product platforms that are covered by patient-beneficial reimbursement programs. Devices used to treat CHF, such as ICDs, VADs, and pacemakers, are eligible for reimbursement.
The major target population for CHF therapy devices is people over the age of 60. This demographic is characterized by low immunity and a proclivity for chronic diseases, such as cardiovascular disease (CVD), and so serves as a high-impact key driver for the expansion of these products in the coming years. As a result, the most recent cardiac care treatments are projected to extend the life span of the older population. The graph below shows how the number of senior patients, who make up the typical target group for surgical volume increases, would change during the forecasting years.
There is a significant number of fatalities that are being caused by cardiovascular diseases in this region. As evidence of the spread of heart disease across socioeconomic and geographical borders emerges, European policymakers are being compelled to make enhancements in cardiovascular health a top priority. According to the National Library of Medicine, cardiovascular diseases already cause 4 million fatalities in Europe each year. Mortality from the disease is increasing across Eastern and Central Europe, where it is nearly double that of the European Union's worst-affected countries. The British Heart Foundation in integration with the European Society of Cardiology launched the Winning Hearts campaign in order to boost heart disease's political visibility. Their goal is to ensure that every person born in the year 2000 has the right to live to be at least 65 years old without suffering from preventable cardiovascular disease.
The Germany market dominated the Europe Congestive Heart Failure (CHF) Treatment Devices Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $1,106.8 Million by 2028. The UK market is anticipated to grow at a CAGR of 4.3% during (2022 - 2028). Additionally, The France market would showcase a CAGR of 6% during (2022 - 2028).
Based on Product Type, the market is segmented into Pacemakers, Implantable Cardioverter Defibrillators, Cardiac Resynchronization Therapy, and Ventricular Assist Devices. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Congestive Heart Failure (CHF) Treatment Devices Market Size will Hit $16.5 Billion by 2028, at a CAGR of 5.4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boston Scientific Corporation, MicroPort Scientific Corporation, Abbott Laboratories, Medtronic PLC, Abiomed, Inc., Berlin Heart GmbH, Jarvik Heart, Inc., Lepu Medical Technology (Beijing) Co., Ltd., BIOTRONIK SE & Co. KG, and Osypka Medical GmbH.
Scope of the Study
Market Segments Covered in the Report:
By Product Type
- Pacemakers
- Implantable Cardioverter Defibrillators
- Cardiac Resynchronization Therapy
- Ventricular Assist Devices
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Boston Scientific Corporation
- MicroPort Scientific Corporation
- Abbott Laboratories
- Medtronic PLC
- Abiomed, Inc.
- Berlin Heart GmbH
- Jarvik Heart, Inc.
- Lepu Medical Technology (Beijing) Co., Ltd.
- BIOTRONIK SE & Co. KG
- Osypka Medical GmbH
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Congestive Heart Failure (CHF) Treatment Devices Market, by Product Type
1.4.2 Europe Congestive Heart Failure (CHF) Treatment Devices Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Acquisitions and Mergers: 2018, Jul – 2022, Feb) Leading Players
Chapter 4. Europe Congestive Heart Failure (CHF) Treatment Devices Market by Product Type
4.1 Europe Pacemakers Market by Country
4.2 Europe Implantable Cardioverter Defibrillators Market by Country
4.3 Europe Cardiac Resynchronization Therapy Market by Country
4.4 Europe Ventricular Assist Devices Market by Country
Chapter 5. Europe Congestive Heart Failure (CHF) Treatment Devices Market by Country
5.1 Germany Congestive Heart Failure (CHF) Treatment Devices Market
5.1.1 Germany Congestive Heart Failure (CHF) Treatment Devices Market by Product Type
5.2 UK Congestive Heart Failure (CHF) Treatment Devices Market
5.2.1 UK Congestive Heart Failure (CHF) Treatment Devices Market by Product Type
5.3 France Congestive Heart Failure (CHF) Treatment Devices Market
5.3.1 France Congestive Heart Failure (CHF) Treatment Devices Market by Product Type
5.4 Russia Congestive Heart Failure (CHF) Treatment Devices Market
5.4.1 Russia Congestive Heart Failure (CHF) Treatment Devices Market by Product Type
5.5 Spain Congestive Heart Failure (CHF) Treatment Devices Market
5.5.1 Spain Congestive Heart Failure (CHF) Treatment Devices Market by Product Type
5.6 Italy Congestive Heart Failure (CHF) Treatment Devices Market
5.6.1 Italy Congestive Heart Failure (CHF) Treatment Devices Market by Product Type
5.7 Rest of Europe Congestive Heart Failure (CHF) Treatment Devices Market
5.7.1 Rest of Europe Congestive Heart Failure (CHF) Treatment Devices Market by Product Type
Chapter 6. Company Profiles
6.1 Boston Scientific Corporation
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 Recent strategies and developments:
6.1.5.1 Approvals and Trials:
6.1.5.2 Product Launches and Product Expansions:
6.1.5.3 Acquisition and Mergers:
6.2 MicroPort Scientific Corporation
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.2.5 Recent Strategies and Developments:
6.2.5.1 Approvals and Trials:
6.2.5.2 Product launches and Product Expansions:
6.3 Abbott Laboratories
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.3.5 Recent strategies and developments:
6.3.5.1 Partnerships, Collaborations, and Agreements:
6.3.5.2 Approvals and Trials:
6.3.5.3 Acquisitions and Mergers:
6.3.5.4 Product Launches and Product Expansions:
6.4 Medtronic PLC
6.4.1 Company overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expenses
6.4.5 Recent strategies and developments:
6.4.5.1 Partnerships, Collaborations, and Agreements:
6.5 Abiomed, Inc.
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Regional Analysis
6.5.4 Research & Development Expenses
6.5.5 Recent strategies and developments:
6.5.5.1 Approvals and Trials:
6.5.5.2 Acquisition and Mergers:
6.6 Berlin Heart GmbH
6.6.1 Company Overview
6.6.2 Recent strategies and developments:
6.6.2.1 Partnerships, Collaborations, and Agreements:
6.7 Jarvik Heart, Inc.
6.7.1 Company Overview
6.8 Lepu Medical Technology (Beijing) Co., Ltd.
6.8.1 Company Overview
6.9 BIOTRONIK SE & Co. KG
6.9.1 Company Overview
6.9.2 Recent strategies and developments:
6.9.2.1 Partnerships, Collaborations and Agreements:
6.9.2.2 Approvals & Trials:
6.9.2.3 Product Launches and Product Expansions:
6.10. Osypka Medical GmbH
6.10.1 Company Overview
TABLE 1 Europe Congestive Heart Failure (CHF) Treatment Devices Market, 2018 - 2021, USD Million
TABLE 2 Europe Congestive Heart Failure (CHF) Treatment Devices Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Congestive Heart Failure (CHF) Treatment Devices Market
TABLE 4 Product Launches And Product Expansions– Congestive Heart Failure (CHF) Treatment Devices Market
TABLE 5 Acquisition and Mergers– Congestive Heart Failure (CHF) Treatment Devices Market
TABLE 6 Approvals and Trials - Congestive Heart Failure (CHF) Treatment Devices Market
TABLE 7 Europe Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2018 - 2021, USD Million
TABLE 8 Europe Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2022 - 2028, USD Million
TABLE 9 Europe Pacemakers Market by Country, 2018 - 2021, USD Million
TABLE 10 Europe Pacemakers Market by Country, 2022 - 2028, USD Million
TABLE 11 Europe Implantable Cardioverter Defibrillators Market by Country, 2018 - 2021, USD Million
TABLE 12 Europe Implantable Cardioverter Defibrillators Market by Country, 2022 - 2028, USD Million
TABLE 13 Europe Cardiac Resynchronization Therapy Market by Country, 2018 - 2021, USD Million
TABLE 14 Europe Cardiac Resynchronization Therapy Market by Country, 2022 - 2028, USD Million
TABLE 15 Europe Ventricular Assist Devices Market by Country, 2018 - 2021, USD Million
TABLE 16 Europe Ventricular Assist Devices Market by Country, 2022 - 2028, USD Million
TABLE 17 Europe Congestive Heart Failure (CHF) Treatment Devices Market by Country, 2018 - 2021, USD Million
TABLE 18 Europe Congestive Heart Failure (CHF) Treatment Devices Market by Country, 2022 - 2028, USD Million
TABLE 19 Germany Congestive Heart Failure (CHF) Treatment Devices Market, 2018 - 2021, USD Million
TABLE 20 Germany Congestive Heart Failure (CHF) Treatment Devices Market, 2022 - 2028, USD Million
TABLE 21 Germany Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2018 - 2021, USD Million
TABLE 22 Germany Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2022 - 2028, USD Million
TABLE 23 UK Congestive Heart Failure (CHF) Treatment Devices Market, 2018 - 2021, USD Million
TABLE 24 UK Congestive Heart Failure (CHF) Treatment Devices Market, 2022 - 2028, USD Million
TABLE 25 UK Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2018 - 2021, USD Million
TABLE 26 UK Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2022 - 2028, USD Million
TABLE 27 France Congestive Heart Failure (CHF) Treatment Devices Market, 2018 - 2021, USD Million
TABLE 28 France Congestive Heart Failure (CHF) Treatment Devices Market, 2022 - 2028, USD Million
TABLE 29 France Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2018 - 2021, USD Million
TABLE 30 France Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2022 - 2028, USD Million
TABLE 31 Russia Congestive Heart Failure (CHF) Treatment Devices Market, 2018 - 2021, USD Million
TABLE 32 Russia Congestive Heart Failure (CHF) Treatment Devices Market, 2022 - 2028, USD Million
TABLE 33 Russia Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2018 - 2021, USD Million
TABLE 34 Russia Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2022 - 2028, USD Million
TABLE 35 Spain Congestive Heart Failure (CHF) Treatment Devices Market, 2018 - 2021, USD Million
TABLE 36 Spain Congestive Heart Failure (CHF) Treatment Devices Market, 2022 - 2028, USD Million
TABLE 37 Spain Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2018 - 2021, USD Million
TABLE 38 Spain Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2022 - 2028, USD Million
TABLE 39 Italy Congestive Heart Failure (CHF) Treatment Devices Market, 2018 - 2021, USD Million
TABLE 40 Italy Congestive Heart Failure (CHF) Treatment Devices Market, 2022 - 2028, USD Million
TABLE 41 Italy Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2018 - 2021, USD Million
TABLE 42 Italy Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2022 - 2028, USD Million
TABLE 43 Rest of Europe Congestive Heart Failure (CHF) Treatment Devices Market, 2018 - 2021, USD Million
TABLE 44 Rest of Europe Congestive Heart Failure (CHF) Treatment Devices Market, 2022 - 2028, USD Million
TABLE 45 Rest of Europe Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2018 - 2021, USD Million
TABLE 46 Rest of Europe Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2022 - 2028, USD Million
TABLE 47 key Information – Boston Scientific Corporation
TABLE 48 key Information – MicroPort Scientific Corporation
TABLE 49 Key Information – Abbott Laboratories
TABLE 50 Key Information – Medtronic PLC
TABLE 51 Key Information – ABIOMED, Inc.
TABLE 52 Key Information – Berlin Heart GmbH
TABLE 53 Key Information – JARVIK HEART, INC.
TABLE 54 Key Information – Lepu Medical Technology (Beijing) Co., Ltd.
TABLE 55 Key Information – BIOTRONIK SE & Co. KG
TABLE 56 Key Information – Osypka Medical GmbH
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Key Strategic Move: (Acquisitions and Mergers: 2018, Jul – 2022, Feb) Leading Players
FIG 5 Recent strategies and developments: Boston Scientific Corporation
FIG 6 Recent Strategies and Developments: MicroPort Scientific Corporation
FIG 7 Recent strategies and developments: Abbott Laboratories
FIG 8 Recent strategies and developments: Abiomed, Inc.